Rare non-syndromic intellectual disability

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Rare non-syndromic intellectual disability.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

ALYFTREK

Vertex Pharmaceuticals Incorporated

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Rare non-syndromic intellectual disability.
Search all trials →
Search clinical trials for Rare non-syndromic intellectual disability

Recent News & Research

1 article
BREAKINGFDA

FDA Approves ALYFTREK

ALYFTREK (DEUTIVACAFTOR) received FDA approval.

Read ↗

Browse all Rare non-syndromic intellectual disability news →

Specialist Network

No specialists currently listed for Rare non-syndromic intellectual disability.

View all Rare non-syndromic intellectual disability specialists →

Quick Actions